Jun 20, 2025 • Zacks Commentary
NEUTRAL
Viking Therapeutics, Inc. ( VKTX ) Dips More Than Broader Market: What You Should Know
In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $26.01, indicating a -1.03% shift from the previous trading day.
Jun 18, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Can Ozempic, Wegovy Drive Further Growth for NVO in the Obesity Space?
Novo Nordisk sees soaring demand for Ozempic and Wegovy as label expansions and manufacturing boosts fuel obesity market gains.
Jun 18, 2025 • Motley Fool
NEUTRAL
Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.
Eli Lilly ( NYSE: LLY ) has been one of the hottest healthcare stocks to own in recent years, thanks in large part to the success of its incredibly successful GLP-1 agonist drugs, which help patients with diabetes and weight loss.
Jun 16, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Novo Nordisk Stock Rises 6% in a Week: What Should Investors Do?
NVO jumps nearly 6% in a week on amycretin pipeline boost and hedge fund interest, but competition looms large.
Jun 16, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Brokers Suggest Investing in Viking Therapeutics ( VKTX ) : Read This Before Placing a Bet
According to the average brokerage recommendation (ABR), one should invest in Viking Therapeutics (VKTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Jun 16, 2025 • Motley Fool
SOMEWHAT-BULLISH
Are These 2 High-Flying Growth Stocks Still Worth Buying After Recent Pullbacks?
When markets get jittery, high-growth stocks often take the biggest hits. But for investors with a stomach for volatility and an eye for transformative potential, these pullbacks can create exceptional opportunities.Last Friday's market turbulence sent the S&P 500 down 1.13%, with growth stocks ...